Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record shows termination and updated recruitment status, indicating that active enrollment has ended. The version history adds new entries such as a document section and study design dated 2026-05-19 and 2026-05-22 to document these changes.
    Difference
    0.8%
    Check dated 2026-05-24T09:29:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page history, replacing v3.5.3. This indicates a new revision of the study record in ClinicalTrials.gov's history log.
    Difference
    0.1%
    Check dated 2026-05-17T00:13:43.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s software revision label has been updated from v3.5.2 to v3.5.3, reflecting a backend/site version change rather than an update to the trial record.
    Difference
    0.1%
    Check dated 2026-04-25T06:16:55.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added a new Study Status entry on 2026-04-16 with Revision: v3.5.2 (version 17). The prior revision v3.5.0 (2025-10-27) was removed from the history.
    Difference
    0.4%
    Check dated 2026-04-18T03:52:38.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 added and v3.4.3 removed in the study record history.
    Difference
    0.1%
    Check dated 2026-03-20T06:57:19.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-05T19:39:43.000Z thumbnail image

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.